{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bladder+Tumor+%28TURBT%29", "query": { "condition": "Bladder Tumor (TURBT)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 23, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Bladder+Tumor+%28TURBT%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-26T05:57:14.016Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02660645", "title": "Blue Light Cystoscopy With Cysview® Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "Hexaminolevulinate hydrochloride (HCL)", "type": "DRUG" }, { "name": "Karl Storz D-Light C Photodynamic Diagnostic (PDD) system", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Photocure", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4400, "start_date": "2014-04", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 18 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02660645" }, { "nct_id": "NCT01310803", "title": "Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma in Situ", "Transitional Cell Carcinoma", "Non-muscle Invasive Bladder Cancer" ], "interventions": [ { "name": "VALSTAR - Maintenance Therapy", "type": "DRUG" }, { "name": "No Maintenance treatment ( Standard of Care)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2011-05", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2017-10-05", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Denver, Colorado • Cumberland, Maryland + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Cumberland", "state": "Maryland" }, { "city": "Sewell", "state": "New Jersey" }, { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310803" }, { "nct_id": "NCT04369560", "title": "Virtual Histology of the Bladder Wall for Bladder Cancer Staging", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Urinary Bladder Neoplasms" ], "interventions": [ { "name": "Magnetic Resonance Imaging", "type": "DIAGNOSTIC_TEST" }, { "name": "Gadobutrol intravesical administration (4mM)", "type": "DRUG" }, { "name": "Ferumoxytol intravesical administration (5 mM)", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "Jodi Maranchie", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 42, "start_date": "2025-05-23", "completion_date": "2028-12-30", "has_results": false, "last_update_posted_date": "2025-12-17", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04369560" }, { "nct_id": "NCT02010203", "title": "A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "HS-410", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "BCG", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Heat Biologics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 104, "start_date": "2013-12", "completion_date": "2018-04", "has_results": true, "last_update_posted_date": "2020-02-17", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 19, "location_summary": "Los Angeles, California • Sherman Oaks, California • Torrance, California + 16 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sherman Oaks", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02010203" }, { "nct_id": "NCT00445601", "title": "S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "gemcitabine hydrochloride", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 406, "start_date": "2007-09", "completion_date": "2017-06", "has_results": true, "last_update_posted_date": "2020-01-18", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 70, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Sacramento, California + 44 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00445601" }, { "nct_id": "NCT00461591", "title": "Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "Apaziquone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "TURBT", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Spectrum Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 802, "start_date": "2007-04", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2021-03-30", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 74, "location_summary": "Anchorage, Alaska • Phoenix, Arizona • Sun City, Arizona + 68 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Burbank", "state": "California" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00461591" }, { "nct_id": "NCT05483868", "title": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Non-muscle-invasive Bladder Cancer", "NMIBC", "Non-Muscle Invasive Bladder Carcinoma", "Non-Muscle Invasive Bladder Neoplasms", "Non-Muscle Invasive Bladder Urothelial Carcinoma", "Urothelial Carcinoma Bladder" ], "interventions": [ { "name": "AU-011", "type": "DRUG" }, { "name": "AU-011 in Combination with Medical Laser Adminstration", "type": "COMBINATION_PRODUCT" }, { "name": "AU-011 in Combination with Medical Laser Administration", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2022-09-26", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-04-15", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 11, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Santa Monica, California + 6 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "The Bronx", "state": "New York" }, { "city": "Myrtle Beach", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05483868" }, { "nct_id": "NCT00598806", "title": "Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "Apaziquone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "TURBT", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Spectrum Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 812, "start_date": "2007-08", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2017-11-13", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 21, "location_summary": "Anaheim, California • West Palm Beach, Florida • Marietta, Georgia + 17 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Roswell", "state": "Georgia" }, { "city": "Hines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00598806" }, { "nct_id": "NCT03839472", "title": "Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non-muscle Invasive Bladder Cancer (NMIBC)", "Bladder Tumor (TURBT)" ], "interventions": [ { "name": "CBI", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-09-01", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2022-05-11", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03839472" }, { "nct_id": "NCT04688931", "title": "A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer", "Urothelial Carcinoma", "Urothelial Carcinoma Bladder" ], "interventions": [ { "name": "UGN-102", "type": "DRUG" }, { "name": "TURBT", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "UroGen Pharma Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 282, "start_date": "2021-02-19", "completion_date": "2023-03-17", "has_results": true, "last_update_posted_date": "2024-06-06", "last_synced_at": "2026-06-26T05:57:14.016Z", "location_count": 33, "location_summary": "Tucson, Arizona • Loma Linda, California • Los Angeles, California + 30 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04688931" } ] }